Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database.

@article{Asomaning2016PregabalinPI,
  title={Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database.},
  author={K Asomaning and Staci J Abramsky and Qian Liu and Xin Zhou and Rachel E. Sobel and Stephen Watt},
  journal={International journal of clinical practice},
  year={2016},
  volume={70 5},
  pages={380-8}
}
AIM In Europe, pregabalin is approved for treatment of neuropathic pain, general anxiety disorder (GAD) and as adjunctive therapy for epilepsy. The purpose of this study was to assess utilisation of pregabalin in the UK, including patients with a recorded history of substance abuse, from a large general practice database. METHODS This observational drug utilisation study (DUS) analysed pregabalin prescription data from the UK Health Improvement Network primary care database between September… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Similar Papers

Loading similar papers…